Lundbeck Wins Appellate Ruling On Cipralex Patent

Law360, New York (April 11, 2008, 12:00 AM EDT) -- A British appellate court has overturned a ruling that found claims in H. Lundbeck A/S’ patent for its antidepressant drug Cipralex insufficient, scoring a win for the Danish pharmaceutical company in an ongoing patent challenge brought by three generics makers.

In a sweeping victory for Lundbeck, a three-judge panel in the Supreme Court of Judicature, Court of Appeal in England and Wales overturned part of the lower court’s ruling that deemed Lundbeck’s patent insufficient and affirmed the rest of the ruling on Thursday, acknowledging the validity...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.